H2S and Endometrial Angiogenesis
H2S 与子宫内膜血管生成
基本信息
- 批准号:10217220
- 负责人:
- 金额:$ 7.85万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-08-01 至 2023-07-31
- 项目状态:已结题
- 来源:
- 关键词:Angiogenesis PromoterAngiogenic FactorApplications GrantsAreaArteriesBiologyBiopsyBirthCell Culture TechniquesCell modelCellsCesarean sectionCoculture TechniquesCystathionineCysteineDataDecidual Cell ReactionsDiscipline of obstetricsDiseaseEmbryoEndometrialEndometrial Stromal CellEndometriumEndothelial CellsEnzymesEstradiolEstrogen Receptor alphaEstrogen Receptor betaEstrogen ReceptorsEstrogensFemaleFertilityFutureGenetic TranscriptionGoalsGonadal Steroid HormonesGrantGynecologicHumanHydrogen SulfideHysterectomyImpairmentIn VitroInfertilityInvestigationKnock-outLinkLyaseMalignant NeoplasmsMammalian OviductsMaternal-fetal medicineMediatingMenstrual cycleModelingMusNatural regenerationOrganOutcomePeriodicityPhasePhysiologicalPlacentationPlayPostmenopausePre-EclampsiaPregnancyPregnancy MaintenanceProcessProductionProgesteroneRegulationReplacement TherapyReportingReproductionResearchRoleSamplingSheepSignaling MoleculeSmooth MuscleSteroidal EstrogenSystemTestingTimeTissuesUp-RegulationUterusVascular Endothelial Growth FactorsVasodilationVasodilator AgentsWomanangiogenesisendometriosisin vivoindexingmigrationnew therapeutic targetnovelparacrinepregnantproliferative phase Menstrual cyclepromoterprotein expressiontrophoblast
项目摘要
Project Summary
New vessel formation from existing vessels termed angiogenesis is a key mechanism for endometrial
turnover and regeneration during the menstrual cycle and normal pregnancy during which estrogens play
a critical role. Angiogenesis in endometrium, like it occurs in any other organs, is initiated by enhanced
local production of angiogenic factors. Hydrogen sulfide (H2S) is a gaseous signaling molecule that
participates into the regulation of numerous physiological and pathophysiological processes. Endogenous
H2S is mainly produced from L-cysteine by cystathionine-β-synthase (CBS) and cystathionine-γ-lyase
(CSE). H2S is a potent proangiogenic vasodilator because H2S donors promote endothelial cell (EC)
angiogenesis in vitro and in vivo. CBS and CSE have been found in many organs but their expression is
tissue/cell-specific; both are needed to generate H2S in some tissues while one enzyme is sufficient in
others. Recent studies have implicated a role of H2S in regulating endometrial function during the
menstrual cycle and pregnancy; however, hitherto it has reported whether endometrial H2S generating
system is regulated during the menstrual cycle and pregnancy and whether H2S plays a role in endometrial
angiogenesis. The overall hypothesis of this RO3 is that elevated estrogens stimulate estrogen
receptor (ERα/β) dependent upregulation of stromal CBS-H2S production, which in turn stimulates
EMEC angiogenesis during the proliferative phase and pregnancy in women. This hypothesis will be
tested by using endometrial biopsies from Cesarean hysterectomies and primary endometrial stromal cells
(ESC) and endometrial microvascular endothelial cells (EMEC) cell models derived from these tissues.
Aim 1 will determine if endometrial H2S production correlates to endometrial angiogenesis index under the
influence of endogenous estrogens in women ex vivo; Aim 2 To determine if estrogens stimulate ESC H2S
production is mediated via ER (ERα/ER) dependent CBS transcription and in vitro; and Aim 3 will
determine if ESC-derived H2S mediates estrogen stimulation of EMEC angiogenesis. Accomplishing these
important specific aims will establish a new paracrine physiological role of ESC-derived H2S in endometrial
EMEC angiogenesis.
项目概要
从现有血管形成新血管(称为血管生成)是子宫内膜异位症的关键机制
月经周期和正常怀孕期间雌激素发挥作用的周转和再生
一个关键的角色。子宫内膜中的血管生成,就像发生在任何其他器官中一样,是由增强的
血管生成因子的局部产生。硫化氢 (H2S) 是一种气态信号分子,
参与许多生理和病理生理过程的调节。内源性
H2S 主要由胱硫醚-β-合酶 (CBS) 和胱硫醚-γ-裂解酶从 L-半胱氨酸产生
(CSE)。 H2S 是一种有效的促血管生成血管舒张剂,因为 H2S 供体可促进内皮细胞 (EC)
体外和体内血管生成。 CBS和CSE已在许多器官中发现,但它们的表达是
组织/细胞特异性;在某些组织中,这两种酶都需要产生 H2S,而其中一种酶就足够了
其他的。最近的研究表明,H2S 在子宫内膜功能调节中发挥着重要作用。
月经周期和怀孕;然而,迄今为止已有报道子宫内膜是否产生H2S
系统在月经周期和怀孕期间受到调节以及H2S是否在子宫内膜中发挥作用
血管生成。 RO3 的总体假设是雌激素升高会刺激雌激素
受体 (ERα/β) 依赖性上调基质 CBS-H2S 的产生,进而刺激
女性增殖期和妊娠期间的 EMEC 血管生成。这个假设将是
通过使用剖腹产子宫切除术的子宫内膜活检和原代子宫内膜基质细胞进行测试
(ESC) 和子宫内膜微血管内皮细胞 (EMEC) 细胞模型源自这些组织。
目标 1 将确定子宫内膜 H2S 产生是否与子宫内膜血管生成指数相关
内源性雌激素对女性离体的影响;目标 2 确定雌激素是否刺激 ESC H2S
生产是通过 ER (ERα/ER) 依赖的 CBS 转录和体外介导的;目标 3 将
确定 ESC 衍生的 H2S 是否介导 EMEC 血管生成的雌激素刺激。实现这些
重要的具体目标将建立 ESC 衍生的 H2S 在子宫内膜中新的旁分泌生理作用
EMEC 血管生成。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DONGBAO CHEN其他文献
DONGBAO CHEN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DONGBAO CHEN', 18)}}的其他基金
H2S and Uterine Vasodilation in Pregnancy and Preeclampsia
妊娠和先兆子痫中的 H2S 与子宫血管舒张
- 批准号:
10274204 - 财政年份:2021
- 资助金额:
$ 7.85万 - 项目类别:
H2S and Uterine Vasodilation in Pregnancy and Preeclampsia
妊娠和先兆子痫中的 H2S 与子宫血管舒张
- 批准号:
10646404 - 财政年份:2021
- 资助金额:
$ 7.85万 - 项目类别:
H2S and Uterine Vasodilation in Pregnancy and Preeclampsia
妊娠和先兆子痫中的 H2S 与子宫血管舒张
- 批准号:
10454412 - 财政年份:2021
- 资助金额:
$ 7.85万 - 项目类别:
Caveolin-1, Caveolae and Placental Angiogenesis
Caveolin-1、Caveolae 和胎盘血管生成
- 批准号:
6821496 - 财政年份:2004
- 资助金额:
$ 7.85万 - 项目类别:
Caveolin-1, Caveolae and Placental Angiogenesis
Caveolin-1、Caveolae 和胎盘血管生成
- 批准号:
7078579 - 财政年份:2004
- 资助金额:
$ 7.85万 - 项目类别:
Caveolin-1, Caveolae and Placental Angiogenesis
Caveolin-1、Caveolae 和胎盘血管生成
- 批准号:
7240598 - 财政年份:2004
- 资助金额:
$ 7.85万 - 项目类别:
Caveolin-1, Caveolae and Placental Angiogenesis
Caveolin-1、Caveolae 和胎盘血管生成
- 批准号:
7645914 - 财政年份:2004
- 资助金额:
$ 7.85万 - 项目类别:
相似海外基金
How angiogenic factor induces immunosuppressive cells to tumor microenvironment
血管生成因子如何诱导免疫抑制细胞进入肿瘤微环境
- 批准号:
22KJ0818 - 财政年份:2023
- 资助金额:
$ 7.85万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Validation of Adenylosuccinate as a Novel Endogenous Pro-Angiogenic Factor in the Brain
腺苷琥珀酸作为大脑中新型内源性促血管生成因子的验证
- 批准号:
10711027 - 财政年份:2021
- 资助金额:
$ 7.85万 - 项目类别:
Validation of Adenylosuccinate as a Novel Endogenous Pro-Angiogenic Factor in the Brain
腺苷琥珀酸作为大脑中新型内源性促血管生成因子的验证
- 批准号:
10297199 - 财政年份:2021
- 资助金额:
$ 7.85万 - 项目类别:
Validation of Adenylosuccinate as a Novel Endogenous Pro-Angiogenic Factor in the Brain
腺苷琥珀酸作为大脑中新型内源性促血管生成因子的验证
- 批准号:
10625314 - 财政年份:2021
- 资助金额:
$ 7.85万 - 项目类别:
Validation of Adenylosuccinate as a Novel Endogenous Pro-Angiogenic Factor in the Brain
腺苷琥珀酸作为大脑中新型内源性促血管生成因子的验证
- 批准号:
10405070 - 财政年份:2021
- 资助金额:
$ 7.85万 - 项目类别:
Physiological role of anti-angiogenic factor thrombospondin in the regulation of endometrial function during early pregnancy in cattle
抗血管生成因子血小板反应蛋白在牛妊娠早期子宫内膜功能调节中的生理作用
- 批准号:
20K06385 - 财政年份:2020
- 资助金额:
$ 7.85万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Elucidation of lymphangiogenic regulatory mechanism of angiogenic factor CCN2 through tumor-associated macrophage
阐明血管生成因子CCN2通过肿瘤相关巨噬细胞的淋巴管生成调节机制
- 批准号:
17K11866 - 财政年份:2017
- 资助金额:
$ 7.85万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Elucidation of vascular stabilization mechanism by anti-angiogenic factor vasohibin-1
抗血管生成因子 vasohibin-1 阐明血管稳定机制
- 批准号:
15K20874 - 财政年份:2015
- 资助金额:
$ 7.85万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
angiogenic therapy for cerebral infarction with anti^sense homology derived peptide targeting angiogenic factor
靶向血管生成因子的反义同源肽治疗脑梗死
- 批准号:
15K15523 - 财政年份:2015
- 资助金额:
$ 7.85万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
The development of the anti-angiogenic factor VEGF-A165b quantification methods for cardiovascular disease.
心血管疾病抗血管生成因子 VEGF-A165b 定量方法的开发。
- 批准号:
26860367 - 财政年份:2014
- 资助金额:
$ 7.85万 - 项目类别:
Grant-in-Aid for Young Scientists (B)














{{item.name}}会员




